Teva Pharmaceuticals will sell a generic copy of Mylan’s EpiPen, which became the target of public outrage over its price. The F.D.A. says the shortage of the lifesaving device is ‘short-term ...

Europe’s regulator has called for generic medicines from manufacturers including Novartis’ Sandoz unit, Teva and Mylan to be pulled from the market, after US inspectors found evidence that ...

Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

After handing over $30 million in criminal penalties last summer, Glenmark Pharmaceuticals has agreed to settle with the U.S. government over claims it fixed the price on a popular cholesterol ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a pair of identical randomized trials, an old antibiotic ...

The global methicillin-resistant staphylococcus aureus (MRSA) treatment market infections has underscored an urgent need for ...